MFN2 and Sensorimotor neuropathy: A recent study of dermal fibroblasts from patients with sensorimotor neuropathy due to heterozygous MFN2 loss-of-function mutations also found no overt mitochondrial network abnormalities nor mitochondrial dysfunction in similar conditions (Dang 2022).